Search

Search Constraints

You searched for: Author/Creator Cai, Li

Search Results

54. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial. Issue 4 (April 2015)

55. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial. Issue 4 (April 2015)

56. Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study). (May 2023)

57. Clinical manifestations, immunological features and prognosis of Chinese pediatric systemic lupus erythematosus: A single‐center study. (8th April 2019)

58. Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China. (15th September 2021)